Christian Marsolais

Company: Theratechnologies

Job title: Chief Medical Officer & Vice President of Medical Affairs

Seminars:

SORT1+ TechnologyTM Platform & Novel Peptide Drug Conjugates (PDC’s) Targeting Sortilin (SORT1) 4:30 pm

Learn about the Sortilin receptor, its role in the normal cell and how its role and function change in cancer Understand why sortilin is an important biomarker/target in cancer, it expression levels in solid tumors, how it can be used for novel drug delivery and why it is an ideal candidate for internalization of novel…Read more

day: Day Two